| 今开：1.74 | 昨收：1.74 |
| 最高：1.83 | 最低：1.65 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：8.0261471E7 |
$Cue Biopharma(CUE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-056838 Act: 34 Size: 7 MB 网页链接
$Cue Biopharma(CUE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-056848 Act: 34 Size: 332 KB 网页链接
$Cue Biopharma(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049072 Act: 34 Size: 1 MB 网页链接
$Cue Biopharma(CUE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-049044 Act: 34 Size: 289 KB 网页链接
$Cue Biopharma(CUE)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-049039 Act: 34 Size: 31 MB 网页链接
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接